These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28694053)

  • 21. Human eosinophils express functional CCR7.
    Akuthota P; Ueki S; Estanislau J; Weller PF
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):758-64. PubMed ID: 23449735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis.
    Otero C; Eisele PS; Schaeuble K; Groettrup M; Legler DF
    J Cell Sci; 2008 Aug; 121(Pt 16):2759-67. PubMed ID: 18664492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10.
    Lim HD; Lane JR; Canals M; Stone MJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
    Tateyama M; Fujihara K; Misu T; Itoyama Y
    J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells.
    Iijima N; Yanagawa Y; Clingan JM; Onoé K
    Int Immunol; 2005 Sep; 17(9):1201-12. PubMed ID: 16027136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging role of chemokine receptor 7 in atherosclerosis.
    Schieffer B; Luchtefeld M
    Trends Cardiovasc Med; 2011 Nov; 21(8):211-6. PubMed ID: 22902067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR7/CCL19 controls expression of EDG-1 in T cells.
    Shannon LA; McBurney TM; Wells MA; Roth ME; Calloway PA; Bill CA; Islam S; Vines CM
    J Biol Chem; 2012 Apr; 287(15):11656-64. PubMed ID: 22334704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21.
    Nickel T; Pfeiler S; Summo C; Kopp R; Meimarakis G; Sicic Z; Lambert M; Lackermair K; David R; Beiras-Fernandez A; Kaczmarek I; Weis M
    Mediators Inflamm; 2012; 2012():320953. PubMed ID: 22619482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
    Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
    Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.
    Lee J; Park C; Kim HJ; Lee YD; Lee ZH; Song YW; Kim HH
    Exp Mol Med; 2017 Jul; 49(7):e358. PubMed ID: 28729639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities.
    Yanagawa Y; Onoé K
    Blood; 2003 Jun; 101(12):4923-9. PubMed ID: 12609829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism.
    Vanalken N; Boon K; Doijen J; Schols D; Van Loy T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated concentrations of CCR7 ligands in patients with eosinophilic pneumonia.
    Nureki S; Miyazaki E; Ishi T; Ito T; Takenaka R; Ando M; Kumamoto T
    Allergy; 2013 Nov; 68(11):1387-95. PubMed ID: 24111618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.
    Han L; Zhang L
    Int Immunopharmacol; 2023 Aug; 121():110431. PubMed ID: 37331295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
    Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
    J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational heterogeneity in CCR7 undergoes transitions to specific states upon ligand binding.
    Gaieb Z; Morikis D
    J Mol Graph Model; 2017 Jun; 74():352-358. PubMed ID: 28477575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.